All posts tagged
Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease
The Patent Office has Spoken: What does it Mean for CRISPR in Europe?
UPDATE: No Clear Winner in the CRISPR Patent Battle
Serious Genetic Diseases have a New CRISPR Dream Duo Venture worth in Excess of €275M
Sorry CRISPR, you’ll have to wait another year to win a Nobel Prize!
CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9?
Labiotech UG, All Rights Reserved -
Send this to friend